Commentary on the article: “Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial” Foa EB et al., JAMA Psychiatry. 2022;79(3):193–200 (1)

• Naomi A. Fineberg,
• Eric Hollander,
• Jon E. Grant,
• Samuel R. Chamberlain,
• Lynne M. Drummond,
• Luca Pellegrini,
• Keith R. Laws,
• David Wellsted,
• Jemma Reid,
• Vera Nezgovorova,
• David S. Baldwin

Affiliations

Naomi A. Fineberg

School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom; Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, United Kingdom; University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom

Eric Hollander

Psychiatric Research Institute of Montefiore Einstein, Albert Einstein College of Medicine, Bronx, NY, USA

Jon E. Grant

Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA

Samuel R. Chamberlain

University of Southampton Faculty of Medicine, Southampton, United Kingdom

Lynne M. Drummond

School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom; South West London and St George's NHS Mental Health Trust, United Kingdom

Luca Pellegrini

School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom; Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, United Kingdom; Centre for Psychedelic Research, Imperial College London, London, United Kingdom; Corresponding author at: School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.

Keith R. Laws

School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom

David Wellsted

School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom

Jemma Reid

School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom; Cornwall Partnership NHS Foundation Trust, Cornwall, United Kingdom

Vera Nezgovorova

Psychiatric Research Institute of Montefiore Einstein, Albert Einstein College of Medicine, Bronx, NY, USA

David S. Baldwin

University of Southampton Faculty of Medicine, Southampton, United Kingdom